AIDS and Behavior

, Volume 11, Issue 1, pp 145–150 | Cite as

Severe Anxiety Symptomatology and HIV Risk Behavior Among Hispanic Injection Drug Users in Puerto Rico

  • Juan C. Reyes
  • Rafaela R. Robles
  • Hector M. Colón
  • C. Amalia Marrero
  • Tomás D. Matos
  • José M. Calderón
  • Elizabeth W. Shepard
Original Article

Abstract

Despite an overall decrease in AIDS incidence in Puerto Rico, our studies continue to show high prevalence of HIV risk behaviors among injection drug users (IDUs). This study seeks to evaluate whether the occurrence of injection-related and sex-related HIV risk behaviors among IDUs in Puerto Rico varies with the presence of anxiety symptomatology. Subjects included 557 IDUs, recruited from street settings in poor neighborhoods in Puerto Rico. Symptoms of severe anxiety were reported by 37.1% of the study sample. Participants with severe anxiety symptoms were more likely to share needles, cotton, and rinse water; to pool money to buy drugs; and to engage in backloading, than those without severe anxiety symptoms. Participants with severe anxiety symptomatology were also more likely to practice unprotected vaginal or oral sex. The findings from this study alert HIV prevention and treatment programs to the need to address anxiety disorders within their programs.

Keywords

Drug users Anxiety HIV risk behavior Hispanic Puerto Rico 

References

  1. Barlow, D. H. (1986). Causes of sexual dysfunction: the role of anxiety and cognitive interference. Journal of Consulting and Clinical Psychology, 54, 140–148.PubMedCrossRefGoogle Scholar
  2. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897.PubMedCrossRefGoogle Scholar
  3. Beck, A. T., & Steer, R. A. (1993). Beck anxiety inventory manual. San Antonio, TX: The Psychological Corporation Harcourt Brace & Company.Google Scholar
  4. Brawman-Mintzer, O., & Yonkers, K. A. (2004). New trends in the treatment of anxiety disorders. CNS Spectrums, 8(Suppl 7), 19–27.Google Scholar
  5. Cagle, H. H., Fisher, D. G.; Senter, T. P.; Thurmond, R. D., & Kastar, A. J. (2002). Classifying Skin Lesions of Injection Drug Users: A Method for Corroborating Disease Risk. DHHS Pub. No. (SMA) 03-3771. Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration.Google Scholar
  6. Casey, K. L., Minoshima, S., Morrow, T. J., Koeppe, R. A., & Frey, K. A. (1995). Imaging the brain in pain: potentials, limitations, and implications. Advances in Pain Research and Therapy, 22, 201–211.Google Scholar
  7. Centers for Disease Control and Prevention (2002). HIV/AIDS Surveillance Report, 13(2).Google Scholar
  8. Coles, M. E., Gibb, B. E., & Heimberg, R. G. (2001). Psychometric evaluation of the Beck Depression Inventory in adults with social anxiety disorder. Depression and Anxiety, 14, 145–148.PubMedCrossRefGoogle Scholar
  9. Compton, W. M., Cottler, L. B., Ben-Abdallah, A., Cunningham-Williams, R., & Spitznagel, E. L. (2000). The effects of psychiatric comorbidity on response to an HIV prevention intervention. Drug and Alcohol Dependence, 58, 247–257.PubMedCrossRefGoogle Scholar
  10. Compton, W. M. III, Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., & Spitznagel, E. L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry, 60, 890–895.CrossRefGoogle Scholar
  11. Compton, W. M., Cottler, L. B., Shillington, A. M., & Price, R. K. (1995). Is antisocial personality disorder associated with increased HIV risk behaviors in cocaine users? Drug and Alcohol Dependence, 37, 37–43.PubMedCrossRefGoogle Scholar
  12. Deren, S., Kang, S.-Y., Colón, H. M., Andía, J. F., Robles, R. R., Oliver-Vélez, D., et al. (2003). Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico. American Journal of Public Health, 93, 812–816.PubMedCrossRefGoogle Scholar
  13. Des Jarlais, D. C., Friedman, S. R., Perlis, T., Chapman, T. F., Sotheran, J. L., Paone, D., et al. (1999). Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 67–72.PubMedGoogle Scholar
  14. Finlinson, H. A., Colon, H. M., Lopez, M. S., Robles, R. R., & Cant, J. G. (2005). Injecting shared drugs: an observational study of the process of drug acquisition, preparation, and injection by Puerto Rican drug users. Journal of Psychoactive Drugs, 37, 37–49.PubMedGoogle Scholar
  15. Fisher, D. G., Needle, R., Weatherby, N., Brown, B., Booth, R., Williams, M., et al. (1993). Reliability of drug user self report. Abstract Book, IXth International Conference on AIDS, Berlin, Germany, June 6–11, 1993, 776 [abstract no. PO-C35-3355].Google Scholar
  16. Ford, J. D., Trestman, R. L., Steinberg, K., Tennen, H., & Allen, S. (2004). Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Social Science and Medicine, 58, 2145–2148.PubMedCrossRefGoogle Scholar
  17. Gorman, J. M. (2003). Treating generalized anxiety disorder. Journal of Clinical Psychiatry, 64(Suppl 2), 24–29.PubMedGoogle Scholar
  18. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807–816.PubMedCrossRefGoogle Scholar
  19. Haverkos, H. W., Turner, J. F., Moolchan, E. T., & Cadet, J. L. (1999). Relative rates of AIDS among racial/ethnic groups by exposure categories. Journal of the National Medical Association, 91, 17–24.PubMedGoogle Scholar
  20. Johnson, S. D., Cunningham-Williams, R. M., & Cottler, L. B. (2003). A tripartite of HIV-risk for African American women: the intersection of drug use, violence, and depression. Drug and Alcohol Dependence, 70, 169–75.PubMedCrossRefGoogle Scholar
  21. Kaplan, H. S. (1988). Anxiety and sexual dysfunction. Journal of Clinical Psychiatry, 49(Suppl), 21–25.PubMedGoogle Scholar
  22. Kelley, J. L., & Petry, N. M. (2000). HIV risk behaviors in male substance abusers with and without antisocial personality disorder. Journal of Substance Abuse Treatment, 19, 59–66.PubMedCrossRefGoogle Scholar
  23. Milani, R. M., Parrott, A. C., Turner, J. J., & Fox, H. C. (2004). Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. Addictive Behaviors, 29, 965–971.PubMedCrossRefGoogle Scholar
  24. Murphy, D. A., Durako, S. J., Moscicki, A. B., Vermund, S. H., Ma, Y., Schwarz, D. F., et al. (2001). Adolescent medicine HIV/AIDS research network. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. The Journal of Adolescent Health, 29, 57–63.PubMedCrossRefGoogle Scholar
  25. Needle, R., Weatherby, N., Chitwood, D., Booth, R., Watters, J., Fisher, D. G., et al. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9, 242–250.CrossRefGoogle Scholar
  26. O’Leary, T. A., Rohsenow, D. J., Martin, R., Colby, S. M., Eaton, C. A., & Monti, P. M. (2000). The relationship between anxiety levels and outcome of cocaine abuse treatment. The American Journal of Drug and Alcohol Abuse, 26, 179–194.PubMedCrossRefGoogle Scholar
  27. Perdue, T., Hagan, H., Thiede, H., & Valleroy, L. (2003). Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Education and Prevention, 15, 81–92.PubMedCrossRefGoogle Scholar
  28. Phillips, M. L., Young, A. W., Senior, C., Brammer, M., Andrew, C., Calder, A. J., et al. (1997). A specific neural substrate for perceiving facial expressions of disgust. Nature, 389, 495–498.PubMedCrossRefGoogle Scholar
  29. Robles, R. R., Colón, H. M., & Freeman, D. H. (1993). Copping areas as sampling and recruitment sites for out-of-treatment crack and injection drug users. Drugs and Society, 7, 91–105.CrossRefGoogle Scholar
  30. Robles, R. R., Colón, H. M., Sahai, H., Matos, T. D., Marrero, C. A., & Reyes, J. C. (1992). Behavioral risk factors and human immunodeficiency virus (HIV) prevalence among intravenous drug users in Puerto Rico. American Journal of Epidemiology, 135, 531–540.PubMedGoogle Scholar
  31. Robles, R. R., Reyes, J. C., Colón, H. M., Sahai, H., Marrero, C. A., Matos, T. D., et al. (2004). Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized controlled study. Journal of Substance Abuse Treatment, 27, 145–152.PubMedCrossRefGoogle Scholar
  32. Rynn, M. A., & Brawman-Mintzer, O. (2004). Generalized anxiety disorder: acute and chronic treatment. CNS Spectrums, 9, 716–723.PubMedGoogle Scholar
  33. Stein, M. D., Solomon, D. A., Herman, D. S., Anderson, B. J., & Miller, I. (2003). Depression severity and drug injection HIV risk behaviors. American Journal of Psychiatry, 160, 1659–1662.PubMedCrossRefGoogle Scholar
  34. Weeks, M. R., Singer, M., Grier, M., & Schensul, J. J. (1996). Gender relations, sexuality, and AIDS risk among African American and Latina Women. In: C. F. Sargent and C. B. Brettell (Eds.), Gender and Health: An International Perspective (pp. 338–370). New Jersey: Prentice Hall.Google Scholar
  35. Weeks, J. W., & Heimberg, R. G. (2005). Evaluation of the psychometric properties of the Beck depression inventory in a non-elderly adult sample of patients with generalized anxiety disorder. Depression and Anxiety, 22, 41–44.PubMedCrossRefGoogle Scholar
  36. Williams, C. T., & Latkin, C. A. (2005). The role of depressive symptoms in predicting sex with multiple and high-risk partners. Journal of Acquired Immune Deficiency Syndromes, 38, 69–73.PubMedCrossRefGoogle Scholar
  37. Woodward, L. J. & Fergusson, D. M. (2001). Life course outcomes of young people with anxiety disorders in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1086–1093.PubMedCrossRefGoogle Scholar
  38. Woody, G. E., Metzger, D., Navaline, H., McLellan, T., & O’Brien, C. P. (1997). Psychiatric symptoms, risky behavior, and HIV infection. NIDA Research Monograph, 172, 156–170.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Juan C. Reyes
    • 1
  • Rafaela R. Robles
    • 1
    • 2
  • Hector M. Colón
    • 1
  • C. Amalia Marrero
    • 1
  • Tomás D. Matos
    • 1
  • José M. Calderón
    • 1
  • Elizabeth W. Shepard
    • 1
    • 2
  1. 1.Center for Addiction StudiesUniversidad Central del Caribe, School of MedicineBayamónArgentina
  2. 2.Caribbean Basin and Hispanic Addiction Technology Transfer CenterUniversidad Central del Caribe, School of MedicineBayamónArgentina

Personalised recommendations